Phase I Open-Label Study of P1101 Followed by P1801 in Advanced Solid Tumors

NCT07053904 · clinicaltrials.gov ↗

PHASE1

Phase

ENROLLING_BY_INVITATION

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: Sequential use of P1101 and P1801

Sponsor

PharmaEssentia

Collaborators

[object Object]